American scientists have found that semaglutide, a drug used for diabetes and obesity, can extend lifespan and slow age-related changes in older female mice, according to the website infohub.kz.
Researchers at the University of California, Berkeley, conducted an experiment on mice aged 20 months. Treatment with semaglutide led to a 24% reduction in food intake and a decrease in body weight, primarily due to loss of fat tissue. The median lifespan of the rodents increased from 742 days in the control group to 834 days in those receiving the drug.
In addition to weight loss, semaglutide improved motor activity, muscle function, cognitive abilities, and insulin sensitivity. The study also observed reduced inflammation, slowed cellular aging, and stimulated formation of new neurons in the hippocampus.
Analysis showed that semaglutide partially mimics the effects of caloric restriction, but in some aspects, such as environmental exploration and spatial memory, it outperforms it. The authors emphasize that the findings are based on an animal model, and long-term clinical studies are needed to verify a similar effect in humans.
It is important to note that this material is for informational purposes only and is not a guide to action. The drugs "Ozempic" and "Wegovy" are serious prescription medications with a wide range of contraindications and side effects. Using these medications without a doctor's prescription can cause serious harm to health. Before starting treatment, be sure to consult a qualified specialist.